PART1 and central nervous system cancer: Examples of the former type of function have been seen in animal models of cervical squamous cell carcinoma (Liu et al., 2020), gastric cancer (Han et al., 2020) and glioma (Deng et al., 2022) where up-regulation of PART1 has resulted in reduction of tumor growth.